| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.976 | 0.001 | 0.976 | Histamine release inhibitor | 0.657 0.006 DBMET00488 0.851 0.003 DBMET02110 | ||
| 0.972 | 0.002 | 0.972 | Transcription factor NF kappa B inhibitor | 0.728 0.018 DBMET00488 0.924 0.004 DBMET02110 | ||
| 0.967 | 0 | 0.967 | Cyclooxygenase 3 inhibitor | 0.57 0.003 DBMET00488 0.667 0.002 DBMET02110 | ||
| 0.95 | 0.004 | 0.95 | Apoptosis agonist | 0.793 0.017 DBMET00488 0.949 0.004 DBMET02110 | ||
| 0.947 | 0.005 | 0.947 | Antiinflammatory | 0.916 0.005 DBMET00488 0.935 0.005 DBMET02110 | ||
| 0.938 | 0 | 0.944 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.028 0.019 DBMET00488 0.944 0 DBMET02110 | DBMET02110 | |
| 0.907 | 0.001 | 0.907 | Expectorant | 0.53 0.003 DBMET00488 0.534 0.003 DBMET02110 | ||
| 0.887 | 0.004 | 0.887 | Caspase 9 stimulant | 0.819 0.009 DBMET00488 0.863 0.004 DBMET02110 | ||
| 0.865 | 0.003 | 0.865 | Nitric oxide antagonist | 0.639 0.008 DBMET00488 0.846 0.004 DBMET02110 | ||
| 0.797 | 0.004 | 0.797 | 5 Hydroxytryptamine release stimulant | 0.529 0.023 DBMET00488 0.574 0.017 DBMET02110 | ||
| 0.796 | 0.003 | 0.796 | Hepatoprotectant | 0.768 0.003 DBMET00488 0.726 0.004 DBMET02110 | ||
| 0.788 | 0.004 | 0.879 | Angiogenesis stimulant | 0.879 0.003 DBMET00488 0.414 0.019 DBMET02110 | DBMET00488 | |
| 0.784 | 0.008 | 0.898 | Cyclophilin D inhibitor | 0.898 0.005 DBMET00488 0.653 0.019 DBMET02110 | DBMET00488 | |
| 0.761 | 0.005 | 0.761 | Immunostimulant | 0.606 0.016 DBMET00488 0.569 0.02 DBMET02110 | ||
| 0.735 | 0.002 | 0.735 | AMP-activated protein kinase stimulant | 0.404 0.004 DBMET00488 0.49 0.003 DBMET02110 | ||
| 0.73 | 0.007 | 0.773 | Antithrombotic | 0.773 0.005 DBMET00488 0.38 0.055 DBMET02110 | DBMET00488 | |
| 0.722 | 0.005 | 0.829 | Antioxidant | 0.829 0.004 DBMET00488 0.552 0.015 DBMET02110 | DBMET00488 | |
| 0.702 | 0.004 | 0.702 | Apoptosis antagonist | 0.612 0.009 DBMET00488 0.643 0.005 DBMET02110 | ||
| 0.69 | 0.005 | 0.758 | Hypoglycemic | 0.758 0.004 DBMET00488 0.519 0.014 DBMET02110 | DBMET00488 | |
| 0.684 | 0.01 | 0.684 | Antibacterial | 0.668 0.011 DBMET00488 0.479 0.047 DBMET02110 | ||
| 0.664 | 0.001 | 0.664 | Interferon gamma antagonist | 0.397 0.011 DBMET00488 0.638 0.002 DBMET02110 | ||
| 0.66 | 0.007 | 0.66 | Caspase 3 stimulant | 0.399 0.045 DBMET00488 0.659 0.007 DBMET02110 | ||
| 0.62 | 0.016 | 0.743 | Cholesterol antagonist | 0.743 0.005 DBMET00488 0.476 0.036 DBMET02110 | DBMET00488 | |
| 0.541 | 0.006 | 0.541 | Diuretic | 0.458 0.01 DBMET00488 0.536 0.006 DBMET02110 | ||
| 0.535 | 0.004 | 0.535 | Hemostatic | 0.528 0.004 DBMET00488 0.166 0.052 DBMET02110 | ||
| 0.542 | 0.012 | 0.768 | Free radical scavenger | 0.768 0.004 DBMET00488 0.328 0.044 DBMET02110 | DBMET00488 | |
| 0.53 | 0.012 | 0.58 | Tumour necrosis factor alpha release inhibitor | 0.58 0.008 DBMET00488 0.357 0.036 DBMET02110 | DBMET00488 | |
| 0.515 | 0.005 | 0.515 | Insulin secretagoues | 0.43 0.005 DBMET00488 0.43 0.005 DBMET02110 | ||
| 0.534 | 0.024 | 0.665 | Immunosuppressant | 0.665 0.006 DBMET00488 0.451 0.047 DBMET02110 | DBMET00488 | |
| 0.481 | 0.004 | 0.615 | Protein-tyrosine phosphatase 1B inhibitor | 0.184 0.034 DBMET00488 0.615 0.004 DBMET02110 | DBMET02110 | |
| 0.482 | 0.007 | 0.482 | Non-steroidal antiinflammatory agent | 0.478 0.008 DBMET00488 0.435 0.01 DBMET02110 | ||
| 0.463 | 0.005 | 0.598 | Protein-tyrosine phosphatase inhibitor | 0.191 0.05 DBMET00488 0.598 0.004 DBMET02110 | DBMET02110 | |
| 0.454 | 0.008 | 0.502 | Platelet adhesion inhibitor | 0.502 0.005 DBMET00488 0.212 0.065 DBMET02110 | DBMET00488 | |
| 0.426 | 0.004 | 0.426 | Gastrin inhibitor | 0.258 0.07 DBMET00488 0.423 0.004 DBMET02110 | ||
| 0.418 | 0.007 | 0.46 | Protein kinase stimulant | 0.46 0.005 DBMET00488 0.267 0.022 DBMET02110 | DBMET00488 | |
| 0.399 | 0.009 | 0.523 | Lipid peroxidase inhibitor | 0.523 0.005 DBMET00488 0.308 0.018 DBMET02110 | DBMET00488 | |
| 0.371 | 0.013 | 0.371 | Monophenol monooxygenase inhibitor | 0.302 0.018 DBMET00488 0.144 0.049 DBMET02110 | ||
| 0.378 | 0.027 | 0.481 | Vasodilator | 0.481 0.013 DBMET00488 0.274 0.058 DBMET02110 | DBMET00488 | |
| 0.354 | 0.007 | 0.517 | Cell adhesion inhibitor | 0.517 0.004 DBMET00488 0.13 0.059 DBMET02110 | DBMET00488 | |
| 0.369 | 0.027 | 0.47 | Transcription factor STAT3 inhibitor | 0.176 0.17 DBMET00488 0.47 0.009 DBMET02110 | DBMET02110 | |
| 0.338 | 0.003 | 0.338 | Transcription factor NF kappa B stimulant | 0.319 0.004 DBMET00488 0.317 0.004 DBMET02110 | ||
| 0.349 | 0.017 | 0.505 | Thrombolytic | 0.505 0.005 DBMET00488 0.207 0.049 DBMET02110 | DBMET00488 | |
| 0.343 | 0.014 | 0.427 | Lipocortins synthesis antagonist | 0.174 0.077 DBMET00488 0.427 0.007 DBMET02110 | DBMET02110 | |
| 0.364 | 0.039 | 0.563 | Interleukin 2 agonist | 0.563 0.004 DBMET00488 0.256 0.112 DBMET02110 | DBMET00488 | |
| 0.335 | 0.015 | 0.513 | Peptidyltransferase inhibitor | 0.513 0.003 DBMET00488 | DBMET00488 | |
| 0.355 | 0.034 | 0.468 | Hypolipemic | 0.468 0.015 DBMET00488 0.322 0.042 DBMET02110 | DBMET00488 | |
| 0.424 | 0.105 | 0.665 | Alpha-glucosidase inhibitor | 0.665 0.04 DBMET00488 0.221 0.205 DBMET02110 | DBMET00488 | |
| 0.36 | 0.042 | 0.44 | Hypoxia-inducible factor 1 alpha inhibitor | 0.44 0.022 DBMET00488 0.432 0.023 DBMET02110 | DBMET00488 | |
| 0.31 | 0.005 | 0.546 | Selectin antagonist | 0.546 0.002 DBMET00488 | DBMET00488 | |
| 0.307 | 0.011 | 0.452 | Cholesterol synthesis inhibitor | 0.178 0.033 DBMET00488 0.452 0.003 DBMET02110 | DBMET02110 | |
| 0.349 | 0.053 | 0.513 | Spasmolytic | 0.513 0.021 DBMET00488 0.194 0.125 DBMET02110 | DBMET00488 | |
| 0.33 | 0.035 | 0.599 | DNA synthesis inhibitor | 0.599 0.007 DBMET00488 0.223 0.091 DBMET02110 | DBMET00488 | |
| 0.312 | 0.02 | 0.359 | Melanin inhibitor | 0.359 0.015 DBMET00488 0.206 0.039 DBMET02110 | DBMET00488 | |
| 0.335 | 0.05 | 0.406 | Sodium/bile acid cotransporter inhibitor | 0.23 0.15 DBMET00488 0.406 0.015 DBMET02110 | DBMET02110 | |
| 0.282 | 0.017 | 0.401 | Interleukin 6 antagonist | 0.401 0.007 DBMET00488 0.216 0.033 DBMET02110 | DBMET00488 | |
| 0.275 | 0.011 | 0.389 | Antineoplastic antibiotic | 0.389 0.005 DBMET00488 0.159 0.029 DBMET02110 | DBMET00488 | |
| 0.23 | 0.02 | 0.406 | Topoisomerase I inhibitor | 0.406 0.005 DBMET00488 0.122 0.054 DBMET02110 | DBMET00488 | |
| 0.224 | 0.015 | 0.302 | Xanthine oxidase inhibitor | 0.302 0.007 DBMET00488 0.195 0.02 DBMET02110 | DBMET00488 | |
| 0.249 | 0.041 | 0.339 | P-glycoprotein inhibitor | 0.154 0.111 DBMET00488 0.339 0.023 DBMET02110 | DBMET02110 | |
| 0.213 | 0.008 | 0.213 | Multidrug resistance-associated protein 1 inhibitor | 0.146 0.027 DBMET00488 0.213 0.008 DBMET02110 | ||
| 0.222 | 0.029 | 0.449 | Topoisomerase II inhibitor | 0.449 0.008 DBMET00488 | DBMET00488 | |
| 0.237 | 0.046 | 0.315 | Neurotrophic factor enhancer | 0.315 0.014 DBMET00488 0.257 0.034 DBMET02110 | DBMET00488 | |
| 0.195 | 0.004 | 0.195 | CC chemokine 6 receptor antagonist | 0.181 0.005 DBMET00488 0.162 0.011 DBMET02110 | ||
| 0.216 | 0.039 | 0.713 | Amylase inhibitor | 0.713 0.003 DBMET00488 | DBMET00488 | |
| 0.193 | 0.016 | 0.266 | Topoisomerase II alpha inhibitor | 0.266 0.009 DBMET00488 | DBMET00488 | |
| 0.226 | 0.05 | 0.308 | Insulin sensitizer | 0.19 0.084 DBMET00488 0.308 0.014 DBMET02110 | DBMET02110 | |
| 0.185 | 0.015 | 0.285 | Uric acid excretion stimulant | 0.285 0.005 DBMET00488 0.189 0.015 DBMET02110 | DBMET00488 | |
| 0.168 | 0.004 | 0.168 | Na+ K+ transporting ATPase inhibitor | 0.149 0.006 DBMET00488 0.144 0.007 DBMET02110 | ||
| 0.246 | 0.09 | 0.39 | Transcription factor STAT inhibitor | 0.39 0.021 DBMET02110 | DBMET02110 | |
| 0.156 | 0.003 | 0.198 | Heme oxygenase stimulant | 0.198 0.002 DBMET02110 | DBMET02110 | |
| 0.264 | 0.113 | 0.311 | Angiogenesis inhibitor | 0.311 0.087 DBMET00488 | DBMET00488 | |
| 0.256 | 0.11 | 0.767 | Immunomodulator | 0.767 0.005 DBMET00488 | DBMET00488 | |
| 0.151 | 0.005 | 0.311 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.311 0.004 DBMET02110 | DBMET02110 | |
| 0.151 | 0.007 | 0.204 | Glycine receptor antagonist | 0.204 0.003 DBMET00488 0.109 0.025 DBMET02110 | DBMET00488 | |
| 0.147 | 0.007 | 0.236 | Phosphorylase inhibitor | 0.236 0.004 DBMET00488 0.209 0.005 DBMET02110 | DBMET00488 | |
| 0.19 | 0.051 | 0.486 | Phospholipase C inhibitor | 0.365 0.013 DBMET00488 0.486 0.006 DBMET02110 | DBMET02110 | |
| 0.224 | 0.099 | 0.555 | Interleukin agonist | 0.555 0.006 DBMET00488 | DBMET00488 | |
| 0.146 | 0.027 | 0.43 | Beta glucuronidase inhibitor | 0.43 0.004 DBMET00488 0.1 0.07 DBMET02110 | DBMET00488 | |
| 0.157 | 0.045 | 0.248 | DNA polymerase I inhibitor | 0.248 0.017 DBMET00488 0.205 0.026 DBMET02110 | DBMET00488 | |
| 0.121 | 0.021 | 0.185 | Glutamate release inhibitor | 0.185 0.005 DBMET00488 | DBMET00488 | |
| 0.116 | 0.018 | 0.257 | Potassium channel large-conductance Ca-activated activator | 0.257 0.005 DBMET02110 | DBMET02110 | |
| 0.169 | 0.072 | 0.322 | ATPase inhibitor | 0.322 0.005 DBMET00488 | DBMET00488 | |
| 0.139 | 0.044 | 0.244 | Microtubule formation inhibitor | 0.244 0.01 DBMET00488 0.163 0.031 DBMET02110 | DBMET00488 | |
| 0.1 | 0.009 | 0.1 | Nitric oxide donor | 0.098 0.01 DBMET00488 0.1 0.009 DBMET02110 | ||
| 0.139 | 0.049 | 0.226 | Beta amyloid protein antagonist | 0.226 0.011 DBMET00488 | DBMET00488 | |
| 0.247 | 0.16 | 0.315 | Antiobesity | 0.315 0.106 DBMET00488 0.223 0.183 DBMET02110 | DBMET00488 | |
| 0.235 | 0.149 | 0.509 | Vasodilator, coronary | 0.509 0.014 DBMET00488 | DBMET00488 | |
| 0.148 | 0.066 | 0.195 | Adenylate cyclase stimulant | 0.195 0.016 DBMET00488 0.192 0.017 DBMET02110 | DBMET00488 | |
| 0.12 | 0.039 | 0.184 | Anabolic | 0.128 0.032 DBMET00488 0.184 0.006 DBMET02110 | DBMET02110 | |
| 0.108 | 0.029 | 0.24 | Cell adhesion molecule inhibitor | 0.24 0.007 DBMET00488 | DBMET00488 | |
| 0.086 | 0.017 | 0.176 | Protein 50S ribosomal subunit inhibitor | 0.176 0.005 DBMET00488 | DBMET00488 | |
| 0.097 | 0.029 | 0.097 | Lipase inhibitor | 0.083 0.04 DBMET02110 | ||
| 0.08 | 0.014 | 0.098 | Lipocortins synthesis agonist | 0.098 0.006 DBMET00488 0.079 0.014 DBMET02110 | DBMET00488 | |
| 0.1 | 0.037 | 0.256 | Inducible nitric-oxide synthase inhibitor | 0.256 0.005 DBMET02110 | DBMET02110 | |
| 0.063 | 0.008 | 0.119 | Antibiotic Aminoglycoside-like | 0.119 0.002 DBMET00488 | DBMET00488 | |
| 0.11 | 0.056 | 0.149 | Protease inhibitor | 0.088 0.077 DBMET00488 0.149 0.03 DBMET02110 | DBMET02110 | |
| 0.077 | 0.024 | 0.086 | Transcription factor AP-1 inhibitor | 0.066 0.035 DBMET00488 0.086 0.018 DBMET02110 | DBMET02110 | |
| 0.076 | 0.024 | 0.076 | Estrogen agonist | 0.058 0.031 DBMET00488 0.076 0.024 DBMET02110 | ||
| 0.05 | 0.001 | 0.05 | Telomerase stimulant | 0.046 0.001 DBMET00488 0.034 0.002 DBMET02110 | ||
| 0.066 | 0.019 | 0.139 | Glucose-6-phosphate translocase inhibitor | 0.139 0.004 DBMET00488 | DBMET00488 | |
| 0.09 | 0.046 | 0.145 | 3C-Like protease (SARS coronavirus) inhibitor | 0.145 0.01 DBMET02110 | DBMET02110 | |
| 0.169 | 0.126 | 0.521 | Platelet antagonist | 0.521 0.012 DBMET00488 | DBMET00488 | |
| 0.062 | 0.02 | 0.179 | Heparanase inhibitor | 0.179 0.002 DBMET00488 | DBMET00488 | |
| 0.053 | 0.013 | 0.089 | RNA-directed RNA polymerase stimulant | 0.089 0.007 DBMET02110 | DBMET02110 | |
| 0.04 | 0.004 | 0.045 | Corticosteroid-like | 0.032 0.006 DBMET00488 0.045 0.004 DBMET02110 | DBMET02110 | |
| 0.14 | 0.107 | 0.274 | Antipruritic | 0.274 0.019 DBMET02110 | DBMET02110 | |
| 0.077 | 0.047 | 0.299 | Histone deacetylase stimulant | 0.299 0.004 DBMET00488 | DBMET00488 | |
| 0.077 | 0.047 | 0.299 | Histone deacetylase SIRT1 stimulant | 0.299 0.004 DBMET00488 | DBMET00488 | |
| 0.051 | 0.023 | 0.082 | Neuraminidase (Influenza A) inhibitor | 0.082 0.005 DBMET00488 0.047 0.029 DBMET02110 | DBMET00488 | |
| 0.037 | 0.01 | 0.09 | Protein 30S ribosomal subunit inhibitor | 0.09 0.004 DBMET00488 | DBMET00488 | |
| 0.097 | 0.075 | 0.219 | Toll-Like receptor 4 antagonist | 0.219 0.005 DBMET00488 | DBMET00488 | |
| 0.098 | 0.076 | 0.161 | DNA intercalator | 0.161 0.038 DBMET00488 | DBMET00488 | |
| 0.05 | 0.029 | 0.062 | Microtubule stabilization | 0.062 0.012 DBMET00488 0.059 0.016 DBMET02110 | DBMET00488 | |
| 0.086 | 0.065 | 0.13 | ATPase (Vacuolar H+) inhibitor | 0.13 0.014 DBMET00488 | DBMET00488 | |
| 0.131 | 0.112 | 0.226 | Arachidonic acid antagonist | 0.205 0.029 DBMET00488 0.226 0.014 DBMET02110 | DBMET02110 | |
| 0.031 | 0.012 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 DBMET00488 0.027 0.023 DBMET02110 | DBMET00488 | |
| 0.062 | 0.048 | 0.259 | Neuraminidase (influenza) inhibitor | 0.259 0.004 DBMET00488 | DBMET00488 | |
| 0.121 | 0.113 | 0.708 | NOS3 expression enhancer | 0.708 0.003 DBMET00488 | DBMET00488 | |
| 0.137 | 0.129 | 0.562 | Anesthetic general | 0.562 0.005 DBMET00488 0.147 0.117 DBMET02110 | DBMET00488 | |
| 0.036 | 0.029 | 0.05 | Glucose-6-phosphate dehydrogenase inhibitor | 0.05 0.012 DBMET02110 | DBMET02110 | |
| 0.101 | 0.096 | 0.124 | Estrogen antagonist | 0.124 0.048 DBMET02110 | DBMET02110 | |
| 0.048 | 0.045 | 0.078 | Acetyl-CoA transferase inhibitor | 0.078 0.021 DBMET02110 | DBMET02110 | |
| 0.025 | 0.022 | 0.063 | Toll-Like receptor 4 agonist | 0.063 0.003 DBMET00488 | DBMET00488 | |
| 0.032 | 0.03 | 0.061 | Tubulin agonist | 0.032 0.031 DBMET00488 0.061 0.005 DBMET02110 | DBMET02110 | |
| 0.028 | 0.027 | 0.383 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.383 0.002 DBMET02110 | DBMET02110 | |
| 0.038 | 0.038 | 0.064 | Opioid kappa receptor agonist | 0.064 0.016 DBMET02110 | DBMET02110 | |
| 0.009 | 0.015 | 0.023 | Antibiotic Macrolide-like | 0.023 0.006 DBMET00488 | DBMET00488 | |
| 0.008 | 0.015 | 0.025 | Glucocorticoid agonist | 0.025 0.007 DBMET02110 | DBMET02110 | |
| 0.011 | 0.021 | 0.018 | Progesterone agonist | 0.018 0.013 DBMET02110 | DBMET02110 | |
| 0.039 | 0.05 | 0.281 | Aldosterone antagonist | 0.281 0.003 DBMET02110 | DBMET02110 | |
| 0.028 | 0.04 | 0.037 | HMG CoA reductase inhibitor | 0.037 0.018 DBMET02110 | DBMET02110 | |
| 0.026 | 0.042 | 0.141 | 5-Alpha-reductase inhibitor | 0.141 0.007 DBMET02110 | DBMET02110 | |
| 0.013 | 0.031 | 0.042 | Estrone sulfatase inhibitor | 0.042 0.008 DBMET02110 | DBMET02110 | |
| 0.018 | 0.036 | 0.022 | Vitamin D receptor antagonist | 0.022 0.016 DBMET00488 | DBMET00488 | |
| 0.005 | 0.03 | 0.018 | Purinergic P2Y agonist | 0.018 0.005 DBMET00488 | DBMET00488 | |
| 0.046 | 0.071 | 0.07 | Acetyl-CoA transferase 2 inhibitor | 0.07 0.017 DBMET02110 | DBMET02110 | |
| 0.005 | 0.031 | 0.023 | Purinergic receptor agonist | 0.023 0.006 DBMET00488 | DBMET00488 | |
| 0.005 | 0.031 | 0.023 | Purinergic P2 agonist | 0.023 0.006 DBMET00488 | DBMET00488 | |
| 0.04 | 0.07 | 0.403 | Alpha-mannosidase inhibitor | 0.403 0.001 DBMET00488 | DBMET00488 | |
| 0.017 | 0.052 | 0.064 | Vanilloid 2 agonist | 0.064 0.002 DBMET00488 | DBMET00488 | |
| 0.056 | 0.091 | 0.083 | CDC25A inhibitor | 0.066 0.063 DBMET00488 0.083 0.04 DBMET02110 | DBMET02110 | |
| 0.012 | 0.049 | 0.027 | Retinoid X gamma receptor agonist | 0.027 0.013 DBMET02110 | DBMET02110 | |
| 0.015 | 0.053 | 0.023 | Retinoic acid gamma receptor agonist | 0.023 0.014 DBMET02110 | DBMET02110 | |
| 0.072 | 0.11 | 0.14 | ABCA1 expression enhancer | 0.14 0.02 DBMET02110 | DBMET02110 | |
| 0.038 | 0.078 | 0.221 | Neuraminidase inhibitor | 0.221 0.004 DBMET00488 | DBMET00488 | |
| 0.018 | 0.06 | 0.028 | Retinoid X gamma receptor antagonist | 0.028 0.017 DBMET02110 | DBMET02110 | |
| 0.01 | 0.054 | 0.021 | Retinoid X beta receptor agonist | 0.021 0.015 DBMET02110 | DBMET02110 | |
| 0.01 | 0.057 | 0.017 | Vitamin D receptor agonist | 0.017 0.011 DBMET00488 | DBMET00488 | |
| 0.044 | 0.093 | 0.086 | CDC25B inhibitor | 0.086 0.023 DBMET02110 | DBMET02110 | |
| 0.053 | 0.104 | 0.122 | Ornithine decarboxylase inhibitor | 0.122 0.024 DBMET00488 0.121 0.025 DBMET02110 | DBMET00488 | |
| 0.025 | 0.076 | 0.041 | Retinoic acid alpha receptor agonist | 0.041 0.025 DBMET02110 | DBMET02110 | |
| 0.02 | 0.072 | 0.311 | Estradiol 17 beta-dehydrogenase inhibitor | 0.311 0.003 DBMET02110 | DBMET02110 | |
| 0.096 | 0.149 | 0.361 | Anticoagulant | 0.361 0.02 DBMET00488 | DBMET00488 | |
| 0.043 | 0.098 | 0.18 | Adenine nucleotide translocase inhibitor | 0.18 0.003 DBMET00488 | DBMET00488 | |
| 0.011 | 0.067 | 0.05 | Antibiotic Anthracycline-like | 0.05 0.002 DBMET00488 | DBMET00488 | |
| 0.033 | 0.088 | 0.082 | HIV-1 integrase (Strand Transfer) inhibitor | 0.082 0.03 DBMET00488 | DBMET00488 | |
| 0.025 | 0.085 | 0.422 | Mannosidase inhibitor | 0.422 0.001 DBMET00488 | DBMET00488 | |
| 0.005 | 0.067 | 0.075 | Ileal bile acid transport inhibitor | 0.075 0.003 DBMET00488 | DBMET00488 | |
| 0.008 | 0.07 | 0.018 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.018 0.007 DBMET00488 | DBMET00488 | |
| 0.035 | 0.1 | 0.514 | Phosphofructokinase-1 inhibitor | 0.514 0.002 DBMET00488 | DBMET00488 | |
| 0.094 | 0.159 | 0.198 | Phospholipase A2 inhibitor | 0.198 0.044 DBMET00488 0.161 0.065 DBMET02110 | DBMET00488 | |
| 0.13 | 0.195 | 0.408 | Cyclic AMP phosphodiesterase inhibitor | 0.408 0.015 DBMET00488 | DBMET00488 | |
| 0.064 | 0.135 | 0.245 | Thioredoxin inhibitor | 0.245 0.005 DBMET00488 | DBMET00488 | |
| 0.072 | 0.144 | 0.181 | Cyclooxygenase 1 inhibitor | 0.181 0.043 DBMET00488 | DBMET00488 | |
| 0.153 | 0.237 | 0.433 | Vasodilator, peripheral | 0.433 0.046 DBMET00488 0.221 0.153 DBMET02110 | DBMET00488 | |
| 0.047 | 0.131 | 0.28 | Potassium channel (Ca-activated) activator | 0.28 0.006 DBMET02110 | DBMET02110 | |
| 0.027 | 0.113 | 0.144 | Diacylglycerol O-acyltransferase inhibitor | 0.144 0.004 DBMET02110 | DBMET02110 | |
| 0.092 | 0.18 | 0.16 | Farnesoid X receptor antagonist | 0.16 0.043 DBMET02110 | DBMET02110 | |
| 0.117 | 0.209 | 0.225 | Ca2+-transporting ATPase inhibitor | 0.225 0.002 DBMET00488 0.13 0.121 DBMET02110 | DBMET00488 | |
| 0.01 | 0.104 | 0.022 | Motilin receptor agonist | 0.022 0.017 DBMET00488 | DBMET00488 | |
| 0.057 | 0.152 | 0.594 | UDP-glucose 4-epimerase inhibitor | 0.594 0.001 DBMET00488 | DBMET00488 | |
| 0.029 | 0.132 | 0.109 | Androgen agonist | 0.109 0.012 DBMET02110 | DBMET02110 | |
| 0.027 | 0.132 | 0.332 | Glucose-6-phosphate isomerase inhibitor | 0.332 0.001 DBMET00488 | DBMET00488 | |
| 0.045 | 0.153 | 0.195 | Glycine receptor agonist | 0.195 0.004 DBMET00488 | DBMET00488 | |
| 0.007 | 0.121 | 0.02 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.02 0.007 DBMET00488 | DBMET00488 | |
| 0.079 | 0.194 | 0.163 | Neurotrophic factor | 0.163 0.049 DBMET00488 | DBMET00488 | |
| 0.029 | 0.147 | 0.084 | HIV-1 integrase (3'-Processing) inhibitor | 0.084 0.032 DBMET00488 | DBMET00488 | |
| 0.196 | 0.315 | 0.593 | 5 Hydroxytryptamine release inhibitor | 0.593 0.012 DBMET00488 | DBMET00488 | |
| 0.066 | 0.192 | 0.136 | Cyclooxygenase inhibitor | 0.136 0.082 DBMET00488 | DBMET00488 | |
| 0.062 | 0.192 | 0.103 | Interleukin 12 antagonist | 0.103 0.049 DBMET00488 | DBMET00488 | |
| 0.094 | 0.23 | 0.381 | Antiamyloidogenic | 0.381 0.032 DBMET00488 | DBMET00488 | |
| 0.006 | 0.142 | 0.089 | Squalene synthetase inhibitor | 0.089 0.007 DBMET00488 | DBMET00488 | |
| 0.052 | 0.19 | 0.691 | NADH dehydrogenase inhibitor | 0.691 0.001 DBMET00488 | DBMET00488 | |
| 0.055 | 0.195 | 0.439 | Alkylator | 0.439 0.006 DBMET00488 | DBMET00488 | |
| 0.056 | 0.204 | 0.282 | Bone formation stimulant | 0.282 0.019 DBMET00488 | DBMET00488 | |
| 0.007 | 0.158 | 0.021 | 5-Alpha-reductase 2 inhibitor | 0.021 0.012 DBMET02110 | DBMET02110 | |
| 0.057 | 0.208 | 0.916 | Alpha-N-acetylglucosaminidase inhibitor | 0.916 0.001 DBMET00488 | DBMET00488 | |
| 0.007 | 0.161 | 0.127 | Sodium/glucose cotransporter 2 inhibitor | 0.127 0.002 DBMET00488 | DBMET00488 | |
| 0.009 | 0.167 | 0.1 | Farnesoid X receptor agonist | 0.1 0.004 DBMET02110 | DBMET02110 | |
| 0.015 | 0.174 | 0.141 | Aldose reductase inhibitor | 0.141 0.011 DBMET00488 | DBMET00488 | |
| 0.049 | 0.209 | 0.103 | Cyclooxygenase 2 inhibitor | 0.103 0.101 DBMET00488 | DBMET00488 | |
| 0.046 | 0.212 | 0.637 | Triose-phosphate isomerase inhibitor | 0.637 0.002 DBMET00488 | DBMET00488 | |
| 0.121 | 0.287 | 0.477 | RNA-directed DNA polymerase inhibitor | 0.477 0.012 DBMET00488 | DBMET00488 | |
| 0.006 | 0.174 | 0.018 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.018 0.016 DBMET00488 | DBMET00488 | |
| 0.009 | 0.182 | 0.125 | Sodium/glucose cotransporter inhibitor | 0.125 0.002 DBMET00488 | DBMET00488 | |
| 0.014 | 0.196 | 0.039 | Liver X receptor agonist | 0.039 0.038 DBMET02110 | DBMET02110 | |
| 0.007 | 0.192 | 0.03 | Leukotriene B4 receptor 2 antagonist | 0.03 0.009 DBMET00488 | DBMET00488 | |
| 0.006 | 0.2 | 0.024 | Dopamine D1 agonist | 0.024 0.014 DBMET00488 | DBMET00488 | |
| 0.005 | 0.2 | 0.025 | Adenosine A1 receptor agonist | 0.025 0.016 DBMET00488 | DBMET00488 | |
| 0.024 | 0.22 | 0.131 | Factor IXa inhibitor | 0.131 0.005 DBMET00488 | DBMET00488 | |
| 0.049 | 0.256 | 0.247 | Psychostimulant | 0.247 0.06 DBMET00488 | DBMET00488 | |
| 0.01 | 0.217 | 0.066 | Prostaglandin EP2 antagonist | 0.066 0.036 DBMET00488 | DBMET00488 | |
| 0.003 | 0.211 | 0.1 | Arginase inhibitor | 0.1 0.004 DBMET00488 | DBMET00488 | |
| 0.09 | 0.305 | 0.418 | DNA damaging | 0.418 0.025 DBMET00488 | DBMET00488 | |
| 0.06 | 0.275 | 0.414 | Cell wall synthesis inhibitor | 0.414 0.005 DBMET00488 | DBMET00488 | |
| 0.071 | 0.293 | 0.131 | Growth hormone agonist | 0.131 0.106 DBMET02110 | DBMET02110 | |
| 0.026 | 0.259 | 0.06 | Factor III inhibitor | 0.06 0.017 DBMET00488 | DBMET00488 | |
| 0.04 | 0.277 | 0.258 | Mucolytic | 0.258 0.006 DBMET00488 | DBMET00488 | |
| 0 | 0.239 | 0.004 | Purinergic P2Y6 agonist | 0.004 0.002 DBMET00488 | DBMET00488 | |
| 0.036 | 0.277 | 0.069 | Transcription factor RelA inhibitor | 0.069 0.032 DBMET02110 | DBMET02110 | |
| 0.003 | 0.254 | 0.021 | Purinergic P2Y2 agonist | 0.021 0.002 DBMET00488 | DBMET00488 | |
| 0.025 | 0.277 | 0.061 | CD45 antagonist | 0.061 0.021 DBMET02110 | DBMET02110 | |
| 0.048 | 0.302 | 0.233 | Photosensitizer | 0.233 0.008 DBMET00488 | DBMET00488 | |
| 0.015 | 0.273 | 0.058 | Leukotriene antagonist | 0.058 0.053 DBMET00488 | DBMET00488 | |
| 0.007 | 0.272 | 0.085 | Caspase 2 inhibitor | 0.085 0.005 DBMET00488 | DBMET00488 | |
| 0.003 | 0.269 | 0.015 | 5-Alpha-reductase 1 inhibitor | 0.015 0.013 DBMET02110 | DBMET02110 | |
| 0.004 | 0.273 | 0.028 | Leukotriene B4 receptor 1 antagonist | 0.028 0.02 DBMET00488 | DBMET00488 | |
| 0.007 | 0.282 | 0.057 | Cholesterol ester transfer protein antagonist | 0.057 0.005 DBMET02110 | DBMET02110 | |
| 0.035 | 0.321 | 0.111 | Bile acid receptor antagonist | 0.103 0.044 DBMET00488 0.111 0.03 DBMET02110 | DBMET02110 | |
| 0.039 | 0.328 | 0.268 | Adenylate cyclase inhibitor | 0.268 0.017 DBMET00488 | DBMET00488 | |
| 0.007 | 0.3 | 0.075 | Aromatase inhibitor | 0.075 0.03 DBMET02110 | DBMET02110 | |
| 0.013 | 0.315 | 0.069 | Leukotriene B4 antagonist | 0.069 0.02 DBMET00488 | DBMET00488 | |
| 0.053 | 0.359 | 0.471 | Hexokinase inhibitor | 0.471 0.003 DBMET00488 | DBMET00488 | |
| 0.034 | 0.344 | 0.464 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.464 0.003 DBMET00488 | DBMET00488 | |
| 0.024 | 0.335 | 0.112 | Interferon inducer | 0.112 0.009 DBMET00488 | DBMET00488 | |
| 0.006 | 0.318 | 0.081 | Guanylate cyclase inhibitor | 0.081 0.003 DBMET00488 | DBMET00488 | |
| 0.044 | 0.358 | 0.1 | TRPA1 agonist | 0.1 0.088 DBMET00488 | DBMET00488 | |
| 0.016 | 0.33 | 0.033 | Glutamate (mGluR8) antagonist | 0.033 0.032 DBMET00488 | DBMET00488 | |
| 0.063 | 0.378 | 0.144 | Vanilloid 1 agonist | 0.144 0.045 DBMET00488 | DBMET00488 | |
| 0.035 | 0.36 | 0.158 | Carbonic anhydrase III inhibitor | 0.158 0.026 DBMET00488 | DBMET00488 | |
| 0.057 | 0.387 | 0.272 | DNA repair enzyme inhibitor | 0.272 0.005 DBMET00488 | DBMET00488 | |
| 0.036 | 0.368 | 0.133 | Lanosterol 14 alpha demethylase inhibitor | 0.133 0.019 DBMET02110 | DBMET02110 | |
| 0.045 | 0.377 | 0.19 | Interleukin 4 antagonist | 0.19 0.025 DBMET00488 | DBMET00488 | |
| 0.019 | 0.354 | 0.061 | Topoisomerase II beta inhibitor | 0.061 0.021 DBMET00488 | DBMET00488 | |
| 0.02 | 0.365 | 0.141 | Interferon agonist | 0.141 0.012 DBMET00488 | DBMET00488 | |
| 0.076 | 0.432 | 0.303 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.303 0.023 DBMET00488 0.183 0.089 DBMET02110 | DBMET00488 | |
| 0.024 | 0.408 | 0.112 | Carbonic anhydrase VI inhibitor | 0.112 0.033 DBMET00488 | DBMET00488 | |
| 0.024 | 0.414 | 0.095 | Keratolytic | 0.071 0.063 DBMET00488 0.095 0.034 DBMET02110 | DBMET02110 | |
| 0.005 | 0.407 | 0.023 | Prostaglandin F2 alpha agonist | 0.023 0.015 DBMET00488 | DBMET00488 | |
| 0.01 | 0.43 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 DBMET00488 | DBMET00488 | |
| 0.007 | 0.427 | 0.045 | Liver X receptor alpha agonist | 0.045 0.023 DBMET02110 | DBMET02110 | |
| 0.019 | 0.44 | 0.041 | Heme oxygenase inhibitor | 0.041 0.035 DBMET02110 | DBMET02110 | |
| 0.019 | 0.446 | 0.257 | Cystathionine beta-synthase inhibitor | 0.257 0.014 DBMET00488 | DBMET00488 | |
| 0.033 | 0.463 | 0.139 | Phosphodiesterase 6D inhibitor | 0.139 0.013 DBMET00488 | DBMET00488 | |
| 0.009 | 0.448 | 0.276 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.276 0.004 DBMET00488 | DBMET00488 | |
| 0.001 | 0.452 | 0.011 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET00488 | DBMET00488 | |
| 0.003 | 0.457 | 0.072 | Carbonic anhydrase II inhibitor | 0.072 0.029 DBMET00488 | DBMET00488 | |
| 0.083 | 0.557 | 0.179 | Heat shock protein 70 antagonist | 0.179 0.012 DBMET00488 | DBMET00488 | |
| 0.006 | 0.49 | 0.192 | Argininosuccinate synthase inhibitor | 0.192 0.008 DBMET00488 | DBMET00488 | |
| 0.005 | 0.49 | 0.092 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.092 0.019 DBMET00488 | DBMET00488 | |
| 0.008 | 0.494 | 0.047 | Ceramide glucosyltransferase inhibitor | 0.047 0.009 DBMET00488 | DBMET00488 | |
| 0.008 | 0.508 | 0.034 | Protein kinase C beta I inhibitor | 0.034 0.022 DBMET00488 | DBMET00488 | |
| 0.003 | 0.509 | 0.116 | Fumarate hydratase inhibitor | 0.116 0.005 DBMET00488 | DBMET00488 | |
| 0.076 | 0.603 | 0.312 | Nitric-oxide synthase stimulant | 0.312 0.009 DBMET00488 | DBMET00488 | |
| 0.008 | 0.537 | 0.114 | Androgen antagonist | 0.114 0.037 DBMET02110 | DBMET02110 | |
| 0.003 | 0.537 | 0.096 | Carbonic anhydrase inhibitor | 0.096 0.028 DBMET00488 | DBMET00488 | |
| 0.022 | 0.568 | 0.391 | Aldehyde dehydrogenase inhibitor | 0.391 0.006 DBMET00488 | DBMET00488 | |
| 0.039 | 0.585 | 0.094 | Folate antagonist | 0.094 0.078 DBMET00488 | DBMET00488 | |
| 0.03 | 0.595 | 0.31 | Adenylate kinase inhibitor | 0.31 0.006 DBMET00488 | DBMET00488 | |
| 0.009 | 0.579 | 0.164 | GABA aminotransferase inhibitor | 0.164 0.006 DBMET00488 | DBMET00488 | |
| 0.015 | 0.592 | 0.219 | Glutamate dehydrogenase inhibitor | 0.219 0.009 DBMET00488 | DBMET00488 | |
| 0.004 | 0.586 | 0.19 | Alcohol oxidase inhibitor | 0.19 0.007 DBMET00488 | DBMET00488 | |
| 0.005 | 0.591 | 0.118 | Carbonic anhydrase XIV inhibitor | 0.118 0.007 DBMET00488 | DBMET00488 | |
| 0.002 | 0.587 | 0.098 | Uridine phosphorylase inhibitor | 0.098 0.002 DBMET00488 | DBMET00488 | |
| 0.005 | 0.595 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET00488 | DBMET00488 | |
| 0.005 | 0.596 | 0.038 | Glutamate (mGluR3) agonist | 0.038 0.012 DBMET00488 | DBMET00488 | |
| 0.006 | 0.604 | 0.066 | Squalene epoxidase inhibitor | 0.066 0.016 DBMET00488 | DBMET00488 | |
| 0.005 | 0.605 | 0.218 | Biliverdin reductase inhibitor | 0.218 0.005 DBMET00488 | DBMET00488 | |
| 0.003 | 0.605 | 0.025 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 DBMET00488 | DBMET00488 | |
| 0.016 | 0.619 | 0.089 | Glutamate (mGluR6) antagonist | 0.089 0.016 DBMET00488 | DBMET00488 | |
| 0.02 | 0.633 | 0.22 | Succinate dehydrogenase inhibitor | 0.22 0.035 DBMET00488 | DBMET00488 | |
| 0.008 | 0.629 | 0.044 | Glutamate (mGluR8) agonist | 0.044 0.017 DBMET00488 | DBMET00488 | |
| 0.004 | 0.627 | 0.17 | Acyl-CoA dehydrogenase inhibitor | 0.17 0.007 DBMET00488 | DBMET00488 | |
| 0.017 | 0.646 | 0.143 | Acetylcholine release stimulant | 0.143 0.022 DBMET00488 | DBMET00488 | |
| 0.004 | 0.651 | 0.191 | Carbamoyl phosphate synthetase inhibitor | 0.191 0.008 DBMET00488 | DBMET00488 | |
| 0.015 | 0.674 | 0.366 | DNA methyltransferase I inhibitor | 0.366 0.012 DBMET00488 | DBMET00488 | |
| 0.003 | 0.666 | 0.063 | Prostaglandin-E synthase inhibitor | 0.063 0.059 DBMET02110 | DBMET02110 | |
| 0.009 | 0.678 | 0.164 | Mediator release inhibitor | 0.164 0.023 DBMET00488 | DBMET00488 | |
| 0.002 | 0.67 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 DBMET00488 | DBMET00488 | |
| 0.002 | 0.675 | 0.109 | Ornithine carbamoyltransferase inhibitor | 0.109 0.014 DBMET00488 | DBMET00488 | |
| 0.007 | 0.681 | 0.14 | Cytokine production stimulant | 0.14 0.003 DBMET00488 | DBMET00488 | |
| 0.027 | 0.702 | 0.195 | CF transmembrane conductance regulator agonist | 0.195 0.025 DBMET00488 | DBMET00488 | |
| 0.004 | 0.679 | 0.073 | Toll-Like receptor 2 agonist | 0.073 0.017 DBMET00488 | DBMET00488 | |
| 0.011 | 0.69 | 0.111 | Chelator | 0.111 0.063 DBMET00488 | DBMET00488 | |
| 0.016 | 0.704 | 0.192 | Aldehyde oxidase inhibitor | 0.192 0.109 DBMET00488 | DBMET00488 | |
| 0.01 | 0.699 | 0.413 | Mannose-6-phosphate isomerase inhibitor | 0.413 0.003 DBMET00488 | DBMET00488 | |
| 0.005 | 0.7 | 0.075 | Aconitate hydratase inhibitor | 0.075 0.016 DBMET00488 | DBMET00488 | |
| 0.007 | 0.705 | 0.051 | Kainate receptor agonist | 0.051 0.013 DBMET00488 | DBMET00488 | |
| 0.005 | 0.704 | 0.073 | Protein kinase C eta inhibitor | 0.073 0.027 DBMET00488 | DBMET00488 | |
| 0.002 | 0.702 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 DBMET00488 | DBMET00488 | |
| 0.006 | 0.711 | 0.098 | Adenosine deaminase inhibitor | 0.098 0.006 DBMET00488 | DBMET00488 | |
| 0.006 | 0.716 | 0.062 | Thymidine kinase inhibitor | 0.062 0.013 DBMET00488 | DBMET00488 | |
| 0.01 | 0.721 | 0.161 | Toll-Like receptor 2 antagonist | 0.161 0.045 DBMET00488 | DBMET00488 | |
| 0.014 | 0.725 | 0.389 | DNA methylase inhibitor | 0.389 0.012 DBMET00488 | DBMET00488 | |
| 0.011 | 0.722 | 0.125 | Purinergic P2X1 antagonist | 0.125 0.01 DBMET00488 | DBMET00488 | |
| 0.002 | 0.713 | 0.069 | Carbonic anhydrase I inhibitor | 0.069 0.029 DBMET00488 | DBMET00488 | |
| 0.008 | 0.74 | 0.251 | GABA C receptor agonist | 0.251 0.013 DBMET00488 | DBMET00488 | |
| 0.04 | 0.774 | 0.249 | Calcium channel activator | 0.249 0.149 DBMET00488 | DBMET00488 | |
| 0.007 | 0.744 | 0.068 | Phospholipase D inhibitor | 0.068 0.058 DBMET00488 | DBMET00488 | |
| 0.008 | 0.752 | 0.156 | Carbonic anhydrase XIII inhibitor | 0.156 0.02 DBMET00488 | DBMET00488 | |
| 0.001 | 0.752 | 0.052 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.052 0.008 DBMET00488 | DBMET00488 | |
| 0.002 | 0.776 | 0.037 | Purinergic P2Y15 antagonist | 0.037 0.009 DBMET00488 | DBMET00488 | |
| 0.003 | 0.783 | 0.097 | Glutamate decarboxylase inhibitor | 0.097 0.032 DBMET00488 | DBMET00488 | |
| 0.01 | 0.793 | 0.196 | Sphingomyelinase inhibitor | 0.196 0.01 DBMET00488 | DBMET00488 | |
| 0.004 | 0.794 | 0.137 | Alcohol dehydrogenase inhibitor | 0.137 0.025 DBMET00488 | DBMET00488 | |
| 0.006 | 0.797 | 0.044 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.023 DBMET00488 | DBMET00488 | |
| 0.009 | 0.802 | 0.104 | DOPA decarboxylase inhibitor | 0.104 0.069 DBMET00488 | DBMET00488 | |
| 0.048 | 0.841 | 0.216 | 5 Hydroxytryptamine uptake stimulant | 0.216 0.123 DBMET00488 | DBMET00488 | |
| 0.013 | 0.822 | 0.131 | NADPH oxidase inhibitor | 0.131 0.07 DBMET00488 | DBMET00488 | |
| 0.006 | 0.819 | 0.129 | Creatine kinase inhibitor | 0.129 0.035 DBMET00488 | DBMET00488 | |
| 0.003 | 0.832 | 0.079 | Aminopeptidase I inhibitor | 0.079 0.043 DBMET00488 | DBMET00488 | |
| 0.002 | 0.834 | 0.08 | Porphobilinogen synthase inhibitor | 0.08 0.047 DBMET00488 | DBMET00488 | |
| 0.001 | 0.838 | 0.103 | Carbonic anhydrase IX inhibitor | 0.103 0.019 DBMET00488 | DBMET00488 | |
| 0.004 | 0.852 | 0.155 | Alkaline phosphatase inhibitor | 0.155 0.057 DBMET00488 | DBMET00488 | |
| 0.001 | 0.858 | 0.136 | Carbonic anhydrase XII inhibitor | 0.136 0.014 DBMET00488 | DBMET00488 | |
| 0.001 | 0.864 | 0.046 | Phosphoglycerate kinase inhibitor | 0.046 0.016 DBMET00488 | DBMET00488 | |
| 0.002 | 0.867 | 0.084 | Histidine decarboxylase inhibitor | 0.084 0.04 DBMET00488 | DBMET00488 | |
| 0.004 | 0.873 | 0.03 | Caspase 6 inhibitor | 0.03 0.023 DBMET00488 | DBMET00488 | |
| 0.004 | 0.879 | 0.041 | AICAR transformylase inhibitor | 0.041 0.037 DBMET00488 | DBMET00488 | |
| 0.004 | 0.88 | 0.144 | Ferrochelatase inhibitor | 0.144 0.04 DBMET00488 | DBMET00488 | |
| 0.001 | 0.894 | 0.016 | Adenosine A2 receptor agonist | 0.016 0.011 DBMET00488 | DBMET00488 | |
| 0.008 | 0.903 | 0.145 | Peroxidase inhibitor | 0.145 0.081 DBMET00488 | DBMET00488 | |
| 0.001 | 0.897 | 0.106 | Antimetabolite | 0.106 0.015 DBMET00488 | DBMET00488 | |
| 0.004 | 0.9 | 0.1 | GABA C receptor antagonist | 0.1 0.078 DBMET00488 | DBMET00488 | |
| 0.001 | 0.9 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.02 DBMET00488 | DBMET00488 | |
| 0.006 | 0.905 | 0.089 | Aminopeptidase B inhibitor | 0.089 0.073 DBMET00488 | DBMET00488 | |
| 0.002 | 0.906 | 0.077 | Phenylalanine 4-hydroxylase inhibitor | 0.077 0.04 DBMET00488 | DBMET00488 | |
| 0.003 | 0.913 | 0.076 | Protein kinase C beta inhibitor | 0.076 0.037 DBMET00488 | DBMET00488 | |
| 0.004 | 0.916 | 0.093 | GABA C receptor rho-1 antagonist | 0.093 0.073 DBMET00488 | DBMET00488 | |
| 0.001 | 0.917 | 0.043 | Purinergic P2Y antagonist | 0.043 0.033 DBMET00488 | DBMET00488 | |
| 0.002 | 0.918 | 0.098 | Catalase inhibitor | 0.098 0.039 DBMET00488 | DBMET00488 | |
| 0.006 | 0.923 | 0.153 | Antibacterial (Helicobacter pylori) | 0.153 0.044 DBMET00488 | DBMET00488 | |
| 0.003 | 0.92 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 DBMET00488 | DBMET00488 | |
| 0.017 | 0.935 | 0.186 | Tyrosine 3 hydroxylase inhibitor | 0.186 0.163 DBMET00488 | DBMET00488 | |
| 0.002 | 0.924 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.06 DBMET00488 | DBMET00488 | |
| 0.002 | 0.936 | 0.135 | Pyruvate kinase inhibitor | 0.135 0.13 DBMET00488 | DBMET00488 | |
| 0.003 | 0.94 | 0.094 | Interleukin 1 beta converting enzyme inhibitor | 0.094 0.065 DBMET00488 | DBMET00488 | |
| 0.002 | 0.947 | 0.073 | Adenosine A3 receptor antagonist | 0.073 0.054 DBMET00488 | DBMET00488 | |
| 0.002 | 0.96 | 0.099 | Protein kinase C gamma inhibitor | 0.099 0.079 DBMET00488 | DBMET00488 | |
| 0.001 | 0.969 | 0.052 | Epithelial sodium channel blocker | 0.052 0.043 DBMET00488 | DBMET00488 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |